152 related articles for article (PubMed ID: 34280991)
1. Assessing Interactions between
Morrill KE; Bland VL; Klimentidis YC; Hingle MD; Thomson CA; Garcia DO
Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34280991
[TBL] [Abstract][Full Text] [Related]
2. More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.
Chinchilla-López P; Ramírez-Pérez O; Cruz-Ramón V; Canizales-Quinteros S; Domínguez-López A; Ponciano-Rodríguez G; Sánchez-Muñoz F; Méndez-Sánchez N
Ann Hepatol; 2018 Mar; 17(2):250-255. PubMed ID: 29469042
[TBL] [Abstract][Full Text] [Related]
3. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
[TBL] [Abstract][Full Text] [Related]
4. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
5. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
6. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
[TBL] [Abstract][Full Text] [Related]
7. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
8. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth.
Monga Kravetz A; Testerman T; Galuppo B; Graf J; Pierpont B; Siebel S; Feinn R; Santoro N
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3575-85. PubMed ID: 32561908
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults.
Garcia DO; Morrill KE; Lopez-Pentecost M; Villavicencio EA; Vogel RM; Bell ML; Klimentidis YC; Marrero DG; Thomson CA
Hepatol Commun; 2022 Jun; 6(6):1322-1335. PubMed ID: 35076162
[TBL] [Abstract][Full Text] [Related]
12. Examining genetic associations with hepatic steatosis in Mexican-origin adults.
Trejo MJ; Morrill KE; Klimentidis YC; Garcia DO
Ann Hepatol; 2023; 28(5):101120. PubMed ID: 37271481
[TBL] [Abstract][Full Text] [Related]
13. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
Liu WY; Zheng KI; Pan XY; Ma HL; Zhu PW; Wu XX; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
J Gastroenterol Hepatol; 2020 Jun; 35(6):1057-1064. PubMed ID: 31677195
[TBL] [Abstract][Full Text] [Related]
14. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
[TBL] [Abstract][Full Text] [Related]
15. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY
Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572
[TBL] [Abstract][Full Text] [Related]
16. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
Schmidt KA; Jones RB; Rios C; Corona Y; Berger PK; Plows JF; Alderete TL; Fogel J; Hampson H; Hartiala JA; Cai Z; Allayee H; Nayak KS; Sinatra FR; Harlan G; Pickering TA; Salvy SJ; Mack WJ; Kohli R; Goran MI
J Nutr; 2022 Jul; 152(7):1655-1665. PubMed ID: 35218194
[TBL] [Abstract][Full Text] [Related]
17. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
18. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
Dai G; Liu P; Li X; Zhou X; He S
Medicine (Baltimore); 2019 Feb; 98(7):e14324. PubMed ID: 30762732
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
[TBL] [Abstract][Full Text] [Related]
20. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.
Gavril OI; Arhire LI; Gavril RS; Zota MI; Gherasim A; Nita O; Drugescu A; Oprescu AC; Esanu IM; Mitu F; Graur M; Mihalache L
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
